Seguir
Michel Ducreux
Michel Ducreux
Université Paris-Saclay, Gustave Roussy
Dirección de correo verificada de gustaveroussy.fr
Título
Citado por
Citado por
Año
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
T Conroy, F Desseigne, M Ychou, O Bouché, R Guimbaud, Y Bécouarn, ...
New England journal of medicine 364 (19), 1817-1825, 2011
78622011
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
RS Finn, S Qin, M Ikeda, PR Galle, M Ducreux, TY Kim, M Kudo, V Breder, ...
New England Journal of Medicine 382 (20), 1894-1905, 2020
45782020
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
E Van Cutsem, A Cervantes, R Adam, A Sobrero, JH Van Krieken, ...
Annals of Oncology 27 (8), 1386-1422, 2016
33912016
KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer
A Lievre, JB Bachet, D Le Corre, V Boige, B Landi, JF Emile, JF Côté, ...
Cancer research 66 (8), 3992-3995, 2006
27892006
Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo …
CS Fuchs, J Tomasek, CJ Yong, F Dumitru, R Passalacqua, C Goswami, ...
The Lancet 383 (9911), 31-39, 2014
23842014
Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203
JP Gérard, T Conroy, F Bonnetain, O Bouché, O Chapet, ...
Journal of clinical oncology 24 (28), 4620-4625, 2006
21662006
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab
A Lievre, JB Bachet, V Boige, A Cayre, D Le Corre, E Buc, M Ychou, ...
Journal of clinical oncology 26 (3), 374-379, 2008
19472008
EASL–EORTC clinical practice guidelines: management of hepatocellular carcinoma
EO for Research, European Association for the Study of the Liver
Journal of hepatology 56 (4), 908-943, 2012
15632012
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
M Ducreux, AS Cuhna, C Caramella, A Hollebecque, P Burtin, D Goéré, ...
Annals of oncology 26, v56-v68, 2015
14812015
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial
C Louvet, R Labianca, P Hammel, G Lledo, MG Zampino, T André, ...
Journal of Clinical Oncology 23 (15), 3509-3516, 2005
12532005
Immunogenic death of colon cancer cells treated with oxaliplatin
A Tesniere, F Schlemmer, V Boige, O Kepp, I Martins, F Ghiringhelli, ...
Oncogene 29 (4), 482-491, 2010
11712010
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A Vogel, A Cervantes, I Chau, B Daniele, JM Llovet, T Meyer, JC Nault, ...
Annals of oncology 29, iv238-iv255, 2018
8532018
Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer
P Laurent-Puig, A Cayre, G Manceau, E Buc, JB Bachet, T Lecomte, ...
Journal of clinical oncology 27 (35), 5924-5930, 2009
8502009
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus …
U Vanhoefer, P Rougier, H Wilke, MP Ducreux, AJ Lacave, E Van Cutsem, ...
Journal of Clinical Oncology 18 (14), 2648-2657, 2000
7262000
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
AL Cheng, S Qin, M Ikeda, PR Galle, M Ducreux, TY Kim, HY Lim, M Kudo, ...
Journal of hepatology 76 (4), 862-873, 2022
6962022
Patients with initially unresectable colorectal liver metastases: is there a possibility of cure
R Adam, DA Wicherts, RJ de Haas, O Ciacio, F Lévi, B Paule, M Ducreux, ...
J Clin Oncol 27 (11), 1829-1835, 2009
6892009
Local treatment of unresectable colorectal liver metastases: results of a randomized phase II trial
T Ruers, F Van Coevorden, CJA Punt, JPEN Pierie, I Borel-Rinkes, ...
JNCI: Journal of the National Cancer Institute 109 (9), djx015, 2017
5882017
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
E Mitry, E Baudin, M Ducreux, JC Sabourin, P Rufié, T Aparicio, P Lasser, ...
British journal of cancer 81 (8), 1351-1355, 1999
5761999
Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy
D Elias, F Blot, A El Otmany, S Antoun, P Lasser, V Boige, P Rougier, ...
Cancer 92 (1), 71-76, 2001
5482001
Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year
T de Baere, D Elias, C Dromain, MGE Din, V Kuoch, M Ducreux, V Boige, ...
American Journal of Roentgenology 175 (6), 1619-1625, 2000
5222000
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20